Hu Zhaopeng

Hu Zhaopeng is a declared insider of Ocumension Therapeutics - B (chief executive), with filings sourced from HKEX. In total, 78 filings cover trades dated from 10 July 2020 to 28 September 2026.

Market trades split into 5 purchases and 23 sales (€107k). The totals exclude 24 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and 5 sales.

Most recently, on 2 October 2026, the filings show a transaction in Ocumension Therapeutics - B. The last purchase on record was published on 18 June 2026, which is 129 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 4 days. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.